Insertion of Mirena after Endometrial Resection in Patients with Adenomyosis

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (17)

• Adenomyosis Following Endometrial Rollerball Ablation via openalex
• Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation via openalex
• Does endometrial resection cause adenomyosis? via openalex
• Hysteroscopic Endometrial Resection via openalex
• Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia via openalex
• Morphological changes in hysterectomies after endometrial ablation via openalex
• Surgical and medical treatment of adenomyosis via openalex
• TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD via openalex
• Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
• Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection via openalex
• W2070900245 via openalex
• W2048097238 via openalex
• W2008780563 via openalex
• W2149156614 via openalex
• W1845775519 via openalex
• W2070035023 via openalex
• W2414626269 via openalex

Cited by (50)

• Levonorgestrel Intrauterine Device versus Combined Transcervical Resection of the Endometrium in the Management of Adenomyosis: A Randomized Clinical Trial 2026
• Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping 2024
• The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
• Long-term Efficacy and Safety of Levonorgestrel - releasing Intrauterine System in the Treatment of Adenomyosis: Evidence Mapping and Meta-analysis 2022
• Medical Treatment of Adenomyosis 2022
• A controlled clinical trial comparing potent progestins, LNG‐IUS and dienogest, for the treatment of women with adenomyosis 2021
• A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis 2021
• Current and Prospective Treatment of Adenomyosis 2021
• Adenomyotic Cyst at Menopause Transition: A Combined Treatment 2020
• Conservative Surgery in the Management of Adenomyosis 2019
• The effect of transcervical endometrial resection on clinical symptoms related to intrinsic adenomyosis and junctional zone changes 2019
• Faculty Opinions recommendation of The impact of adenomyosis on women's fertility. 2019
• Combination of microwave endometrial ablation and postoperative dienogest administration is effective for treating symptomatic adenomyosis 2018
• Minimally invasive treatment of adenomyosis 2018
• Operation, hormone therapy and recovery of the patients with severe forms of adenomyosis 2018
• Adenomyosis and Hysteroscopy: An Up-to-Date Review 2017
• Adenomyosis and Hysteroscopy: An Up-to-Date Review 2017
• Levonorgestrel-releasing intrauterine system versus low-dose combined oral contraceptive for treatment of adenomyosis uteri: a randomized clinical trial 2015
• Current Treatment for Adenomyosis 2015
• Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial 2015
• Adenomiosis: tratamiento 2015
• The Role of the Myometrium in Adenomyosis 2015
• The effect of oral contraceptives on aromatase and Cox-2 expression in the endometrium of patients with idiopathic menorrhagia or adenomyosis 2013
• Hysterectomy and levonorgestrel-releasing intrauterine system in the treatment of menorrhagia : a 10-year randomized comparative trial 2012
• Effect of a hormone-releasing intrauterine system (Mirena®) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection 2012
• Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis 2011
• Activation of NF-κB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens 2010
• Levonorgestrelį išskiriančios gimdos spiralės vartojimas ginekologijoje 2009
• Activation of NF-κB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens 2009
• Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS 2009
• The effect of hysterectomy or levonorgestrel‐releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five‐year randomized controlled trial 2009
• Adenomyosis uteri: an update 2009
• Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis 2008
• Dismenorreas 2008
• Non-contraceptive health benefits of oral contraceptives 2008
• Hiérarchisation des stratégies thérapeutiques pour ménométrorragies avec ou sans désir de grossesse 2008
• Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies 2008
• Tratamiento de la adenomiosis 2007
• Traitement de l'adénomyose 2007
• The Levonorgestrel-releasing Intrauterine System: An Updated Review of the Contraceptive and Noncontraceptive Uses 2007
• Hormonal treatments for adenomyosis 2007
• The role of magnetic resonance imaging in minimal access surgery 2006
• New interventional techniques for adenomyosis 2006
• Re-audit: transcervical resection of the endometrium for heavy menstrual bleeding and the treatment of post-resection uterine stenosis and haematometra by cervical dilatation and the insertion of a levonorgestrel-releasing intra-uterine system 2006
• Medicated intrauterine systems for treatment of endometriosis-associated pain 2006
• Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis 2006
• Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overview 2005
• 10.1016/s0246-1064(14)65366-4 2000
• 10.1016/s1241-8234(23)47284-7 2000
• 10.1016/s1959-5182(22)43849-9 2000

Source provenance

europepmc

last seen: 2026-06-18T06:15:08.409253+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:12:38.158000+00:00